Boulay A, Quevarec E, Malet I, Nicastro G, Chamontin C, Perrin S, Henriquet C, Pugnière M, Courgnaud V, Blaise M, Marcelin AG, Taylor IA, Chaloin L, Arhel NJ.

A new class of capsid-targeting inhibitors that specifically block HIV-1 nuclear import.

EMBO Mol Med. 2024 Oct 2. doi: 10.1038/s44321-024-00143-w. Online ahead of print. PMID: 39358603

Remerciement

Pour tous travaux utilisant des équipements du PPM, merci d'utiliser la phrase type de remerciements : "

Mass spectrometry experiments were carried out using the facilities of the Montpellier Proteomics Platform (PPM, BioCampus Montpellier), a member of the national Proteomics French Infrastructure (ProFI UAR 2048) supported by the French National Research Agency (ANR-24-INBS-0015, Investments for the future F2030).

Aller au haut